These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24695354)

  • 1. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
    Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
    Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
    Lopez SA; Mulla H; Durward A; Tibby SM
    Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.
    Plajer SM; Chin PK; Vella-Brincat JW; Buffery PJ; Begg EJ
    Ther Drug Monit; 2015 Feb; 37(1):98-103. PubMed ID: 24943063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
    Moffett BS; Rossano JW
    Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose.
    Gonçalves-Pereira J; Martins A; Póvoa P
    Clin Microbiol Infect; 2010 Aug; 16(8):1258-63. PubMed ID: 19832713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.
    Bialkowski S; Staatz CE; Clark J; Lawson R; Hennig S
    Ther Drug Monit; 2016 Dec; 38(6):693-698. PubMed ID: 27851686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
    Xuan D; Nicolau DP; Nightingale CH
    Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once versus twice daily dose of gentamicin therapy in Thai neonates.
    Kosalaraksa P; Janthep P; Jirapradittha J; Taksaphan S; Kiatchoosakun P
    J Med Assoc Thai; 2004 Apr; 87(4):372-6. PubMed ID: 15217172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily gentamicin dosing in full term neonates.
    Alsaedi SA
    Saudi Med J; 2003 Sep; 24(9):978-81. PubMed ID: 12973482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
    Lackey MN; Belknap EB; Greco DS; Fettman MJ
    Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.